Bagundol, Gloria C.
HRN: 22-80-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/28/2025
CEFUROXIME 1.5GM (VIAL)
01/28/2025
01/28/2025
IV
1.5g
Loading Dose
Endometrial Biopsy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes